The FDA approved the ACR to begin to accredit all previously FDA-approved digital breast tomosynthesis (DBT) systems beginning April 9, 2018.
ACR Now Approved to Accredit DBT Units
Rather than submitting an application to the FDA certificate extension program for DBT units, ACR-accredited facilities can now apply for DBT accreditation with the ACR.
The ACR is now accepting applications for DBT units. To prepare your facility for the new accreditation process, here are two important links:
Watch the ACR Mammography Accreditation page for any future announcements.